ArticleJournal of neuroendocrinology2026

Predictors of in vitro response to somatostatin and dopamine receptor-targeted treatments are lacking in clinically non-functioning pituitary tumors.

Claudia Campana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.